What Should the Goals Be for Diverse Recruitment in Alzheimer Clinical Trials?
JAMA Neurol
; 79(11): 1097-1098, 2022 11 01.
Article
em En
| MEDLINE
| ID: mdl-35969392
This Viewpoint discusses why it's important for Alzheimer clinical trials to be inclusive and enroll diverse populations that include underrepresented racial, ethnic, and sociocultural groups.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Doença de Alzheimer
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article